BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 22907335)

  • 1. Impact of chemotherapeutic agents on the immunostimulatory properties of human 6-sulfo LacNAc+ (slan) dendritic cells.
    Wehner R; Bitterlich A; Meyer N; Kloß A; Schäkel K; Bachmann M; Schmitz M
    Int J Cancer; 2013 Mar; 132(6):1351-9. PubMed ID: 22907335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reciprocal activating interaction between 6-sulfo LacNAc+ dendritic cells and NK cells.
    Wehner R; Löbel B; Bornhäuser M; Schäkel K; Cartellieri M; Bachmann M; Rieber EP; Schmitz M
    Int J Cancer; 2009 Jan; 124(2):358-66. PubMed ID: 18942710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bortezomib significantly impairs the immunostimulatory capacity of human myeloid blood dendritic cells.
    Straube C; Wehner R; Wendisch M; Bornhäuser M; Bachmann M; Rieber EP; Schmitz M
    Leukemia; 2007 Jul; 21(7):1464-71. PubMed ID: 17495970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracorporeal photopheresis efficiently impairs the proinflammatory capacity of human 6-sulfo LacNAc dendritic cells.
    Gerner M; Hölig K; Wehner R; Zhao S; Schäkel K; Bachmann MP; Rieber EP; Bornhäuser M; Schmitz M
    Transplantation; 2009 Apr; 87(8):1134-9. PubMed ID: 19384158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TLR7/8 agonists trigger immunostimulatory properties of human 6-sulfo LacNAc dendritic cells.
    Jähnisch H; Wehner R; Tunger A; Kunze A; Oehrl S; Schäkel K; Rohayem J; Bornhäuser M; Tonn T; Bachmann M; Schmitz M
    Cancer Lett; 2013 Jul; 335(1):119-27. PubMed ID: 23402811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accumulation of tolerogenic human 6-sulfo LacNAc dendritic cells in renal cell carcinoma is associated with poor prognosis.
    Toma M; Wehner R; Kloß A; Hübner L; Fodelianaki G; Erdmann K; Füssel S; Zastrow S; Meinhardt M; Seliger B; Brech D; Noessner E; Tonn T; Schäkel K; Bornhäuser M; Bachmann MP; Wirth MP; Baretton G; Schmitz M
    Oncoimmunology; 2015 Jun; 4(6):e1008342. PubMed ID: 26155414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TNFR2 and IL-12 coactivation enables slanDCs to support NK-cell function via membrane-bound TNF-α.
    Tufa DM; Chatterjee D; Low HZ; Schmidt RE; Jacobs R
    Eur J Immunol; 2014 Dec; 44(12):3717-28. PubMed ID: 25229755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of inflammatory slan (6-sulfo LacNAc) dendritic cells in psoriatic skin of patients treated with etanercept.
    Günther C; Blau K; Förster U; Viehweg A; Wozel G; Schäkel K
    Exp Dermatol; 2013 Aug; 22(8):535-40. PubMed ID: 23879812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The bidirectional crosstalk between human dendritic cells and natural killer cells.
    Wehner R; Dietze K; Bachmann M; Schmitz M
    J Innate Immun; 2011; 3(3):258-63. PubMed ID: 21411969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of p38 mitogen-activated protein kinase inhibition on immunostimulatory properties of human 6-sulfo LacNAc dendritic cells.
    Langosch S; Wehner R; Malecka A; Franks HA; Schäkel K; Bachmann M; Jackson AM; Schmitz M
    Immunobiology; 2016 Feb; 221(2):166-74. PubMed ID: 26391152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The phosphodiesterase 4 inhibitor apremilast inhibits Th1 but promotes Th17 responses induced by 6-sulfo LacNAc (slan) dendritic cells.
    Oehrl S; Prakash H; Ebling A; Trenkler N; Wölbing P; Kunze A; Döbel T; Schmitz M; Enk A; Schäkel K
    J Dermatol Sci; 2017 Aug; 87(2):110-115. PubMed ID: 28499587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal stem cells efficiently inhibit the proinflammatory properties of 6-sulfo LacNAc dendritic cells.
    Wehner R; Wehrum D; Bornhäuser M; Zhao S; Schäkel K; Bachmann MP; Platzbecker U; Ehninger G; Rieber EP; Schmitz M
    Haematologica; 2009 Aug; 94(8):1151-6. PubMed ID: 19546436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human 6-sulfo LacNAc (slan) dendritic cells have molecular and functional features of an important pro-inflammatory cell type in lupus erythematosus.
    Hänsel A; Günther C; Baran W; Bidier M; Lorenz HM; Schmitz M; Bachmann M; Döbel T; Enk AH; Schäkel K
    J Autoimmun; 2013 Feb; 40():1-8. PubMed ID: 22890025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel modular antigen delivery system for immuno targeting of human 6-sulfo LacNAc-positive blood dendritic cells (SlanDCs).
    Bippes CC; Feldmann A; Stamova S; Cartellieri M; Schwarzer A; Wehner R; Schmitz M; Rieber EP; Zhao S; Schäkel K; Temme A; Scofield RH; Kurien BT; Bartsch H; Bachmann M
    PLoS One; 2011 Jan; 6(1):e16315. PubMed ID: 21283706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pollen-derived low-molecular weight factors inhibit 6-sulfo LacNAc+ dendritic cells' capacity to induce T-helper type 1 responses.
    Gilles S; Jacoby D; Blume C; Mueller MJ; Jakob T; Behrendt H; Schaekel K; Traidl-Hoffmann C
    Clin Exp Allergy; 2010 Feb; 40(2):269-78. PubMed ID: 20210806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapeutic agents in noncytotoxic concentrations increase antigen presentation by dendritic cells via an IL-12-dependent mechanism.
    Shurin GV; Tourkova IL; Kaneno R; Shurin MR
    J Immunol; 2009 Jul; 183(1):137-44. PubMed ID: 19535620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infliximab induces downregulation of the IL-12/IL-23 axis in 6-sulfo-LacNac (slan)+ dendritic cells and macrophages.
    Brunner PM; Koszik F; Reininger B; Kalb ML; Bauer W; Stingl G
    J Allergy Clin Immunol; 2013 Nov; 132(5):1184-1193.e8. PubMed ID: 23890755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlling the pro-inflammatory function of 6-sulfo LacNAc (slan) dendritic cells with dimethylfumarate.
    Oehrl S; Olaru F; Kunze A; Maas M; Pezer S; Schmitz M; Schäkel K
    J Dermatol Sci; 2017 Sep; 87(3):278-284. PubMed ID: 28732748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-1β limits the extent of human 6-sulfo LacNAc dendritic cell (slanDC)-mediated NK cell activation and regulates CD95-induced apoptosis.
    Tufa DM; Ahmad F; Chatterjee D; Ahrenstorf G; Schmidt RE; Jacobs R
    Cell Mol Immunol; 2017 Dec; 14(12):976-985. PubMed ID: 27086951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of monomethylfumarate on dendritic cell differentiation.
    Litjens NH; Rademaker M; Ravensbergen B; Thio HB; van Dissel JT; Nibbering PH
    Br J Dermatol; 2006 Feb; 154(2):211-7. PubMed ID: 16433787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.